National Health Investors Stock Current Liabilities
| NHI Stock | USD 60.44 0.89 1.49% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
The National Health's current Non Current Liabilities Total is estimated to increase to about 1.2 B, while Total Current Liabilities is projected to decrease to under 53.2 M. National | Current Liabilities |
National Health Investors Company Current Liabilities Analysis
National Health's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current National Health Current Liabilities | 52.78 M |
Most of National Health's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for National Health is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Current Liabilities. Since National Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National Health's interrelated accounts and indicators.
Click cells to compare fundamentals
National Current Liabilities Historical Pattern
Today, most investors in National Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of National Health current liabilities as a starting point in their analysis.
National Health Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
National Liabilities And Stockholders Equity
Liabilities And Stockholders Equity |
|
In accordance with the recently published financial statements, National Health Investors has a Current Liabilities of 52.78 M. This is 94.47% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The current liabilities for all United States stocks is 99.33% higher than that of the company.
National Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in current liabilities category among related companies.
National Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of National Health from analyzing National Health's financial statements. These drivers represent accounts that assess National Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.5B | 3.1B | 2.6B | 2.3B | 2.4B | 2.5B | |
| Enterprise Value | 5.0B | 4.6B | 3.8B | 3.5B | 3.5B | 3.7B |
National Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0448 | ||||
| Profit Margin | 0.42 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.18 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 4.61 % | ||||
| Shares Owned By Institutions | 64.10 % | ||||
| Number Of Shares Shorted | 874.66 K | ||||
| Price To Earning | 13.23 X | ||||
| Price To Book | 2.02 X | ||||
| Price To Sales | 7.92 X | ||||
| Revenue | 319.83 M | ||||
| Gross Profit | 268.98 M | ||||
| EBITDA | 246.88 M | ||||
| Net Income | 134.38 M | ||||
| Cash And Equivalents | 19.29 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 1.14 B | ||||
| Debt To Equity | 0.78 % | ||||
| Current Ratio | 2.78 X | ||||
| Book Value Per Share | 33.73 X | ||||
| Cash Flow From Operations | 184.45 M | ||||
| Short Ratio | 4.55 X | ||||
| Earnings Per Share | 3.13 X | ||||
| Price To Earnings To Growth | 1.99 X | ||||
| Target Price | 62.83 | ||||
| Number Of Employees | 26 | ||||
| Beta | 0.98 | ||||
| Market Capitalization | 2.62 B | ||||
| Total Asset | 2.49 B | ||||
| Retained Earnings | 2.47 B | ||||
| Working Capital | 285.14 M | ||||
| Current Asset | 73.06 M | ||||
| Current Liabilities | 52.78 M | ||||
| Annual Yield | 0.06 % | ||||
| Five Year Return | 6.01 % | ||||
| Net Asset | 2.49 B | ||||
| Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out National Health Piotroski F Score and National Health Altman Z Score analysis. Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share 7.384 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.